American Covid’ Is Rising Again. But England’s Real Story Is More Complicated

By: Chioma Madonna Ndukwu

American Covid’ Is Rising Again. But England’s Real Story Is More Complicated

England is looking at COVID-19 again, but this time the story feels different. The virus is no longer an emergency; it is an unwelcome familiar visitor.

That is why the latest rise feels strange. People are not rushing for masks or emptying supermarket shelves, yet hospital figures are moving upwards again.

At the centre of attention is XFG, a coronavirus variant that newspapers have nicknamed “American Covid” and health authorities know as Stratus in recent headlines.

The nickname is catchy, but it can also mislead. XFG is not an American disease, and its presence in England is not simply an American import.

XFG has been detected across countries and remains on the World Health Organisation’s list of variants under monitoring, alongside other SARS-CoV-2 lineages being followed closely.

In England, the UK Health Security Agency’s latest figures show COVID-19 cases rising to 1,364 in the seven days ending September 23, after another weekly increase.

That represented a 28.6 per cent increase from the previous seven-day period, giving the latest rise something more substantial than a headline alone over the week before.

Hospital admissions have also increased. The latest available UKHSA figure recorded 261 admissions in the week ending August 31, 34 more than the previous week.

The figures come with an important warning. Recent UK data are affected by reporting delays, meaning the newest weeks can change as hospitals submit additional records.

Still, the movement is enough to make XFG worth watching, especially because the variant has become prominent among sequenced samples collected in England.

Recent UKHSA sequencing found XFG.23.1.3 in 46.2 per cent of available sequences, while another XFG lineage, XFG.14.8, accounted for 12.8 per cent.

Those figures should not be mistaken for the percentage of all infections. Only a portion of positive samples are sequenced, so the picture is incomplete about the entire population.

That distinction matters because a laboratory percentage can look dramatic while saying less about how widely the virus is actually spreading through ordinary households.

Yet viruses have their own way of making statistics personal. A number on a government dashboard can become a hospital bed, a missed shift or worried family over the past several years.

For most people, COVID-19 is no longer what it was in 2020. Vaccination, previous infections and better treatment have changed the picture considerably.

That does not mean the virus has become harmless. It means the risk has changed, and it is now unevenly shared across the population for different groups of people.

Older people remain more vulnerable to severe COVID-19, as do people with weakened immune systems and some people living with underlying health conditions and some long-term medical conditions.

For them, another rise in infections can carry a different meaning from the sore throat or tiredness experienced by an otherwise healthy younger person who may recover without hospital care.

That is why hospital admissions deserve attention even when health authorities are not describing XFG as a more dangerous variant during an otherwise familiar seasonal rise.

A virus does not need to become deadlier before hospitals notice it. More infections can produce more serious cases, simply because more people are infected.

WHO continues to classify XFG as a variant under monitoring. Current evidence has not established that it causes more severe disease than other circulating variants or the variants that came before it today.

The picture is therefore more complicated than the phrase “American Covid” suggests. The real story is about a familiar virus continuing to change.

SARS-CoV-2 has been doing that since the pandemic began. New lineages appear, compete with older ones and sometimes become dominant before losing ground again.

XFG was first documented in early 2025. It later spread internationally, showing once more that coronavirus evolution does not respect borders as the virus continues finding new hosts.

That matters for England because the country is not watching an isolated outbreak. It is watching one part of a much wider pattern of viral circulation.

The symptoms will not necessarily announce which variant has infected someone. Sore throat, cough, fever, tiredness, headache and a blocked nose can all occur too.

Hoarseness has also been reported with XFG, but symptoms alone cannot reliably distinguish COVID-19 from influenza, a cold or another respiratory infection.

This makes testing and surveillance useful, particularly for people at higher risk. Without them, a gradual rise can remain invisible until hospitals begin feeling it.

England is not back in the frightening days of overflowing wards and daily pandemic briefings. Hospital levels remain below those seen during the crisis today.

But the virus has not disappeared. It has settled into a new place in society, where people live with it while scientists continue watching what comes next.